FCER2 and B-cell chronic lymphocytic leukemia: The precise cell-of-origin in CLL remains under debate [10–11] and any direct link to a normal B-cell subset has proven difficult given that no single B-cell population shares the unique CD5+, CD19+, CD20+, and CD23+ immunophenotype characteristic of CLL [6].